Therapeutic Area | MeSH |
---|---|
anesthesia and analgesia | D000760 |
investigative techniques | D008919 |
Tradename | Company | Number | Date | Products |
---|---|---|---|---|
BRIDION | Merck & Co | N-022225 RX | 2015-12-15 | 2 products, RLD |
Brand Name | Status | Last Update |
---|---|---|
bridion | New Drug Application | 2025-01-29 |
Expiration | Code | ||
---|---|---|---|
SUGAMMADEX SODIUM, BRIDION, MSD SUB MERCK | |||
2024-06-25 | NPP | ||
2024-01-22 | M-291 |
Patent | Expires | Flag | FDA Information |
---|---|---|---|
Sugammadex Sodium, Bridion, Msd Sub Merck | |||
RE44733 | 2026-01-27 | DS, DP | U-1794 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Neuromuscular blockade | D019148 | — | — | — | 3 | 8 | 16 | 3 | 30 |
Anesthesia | D000758 | — | — | — | — | 5 | 1 | — | 6 |
Postoperative complications | D011183 | — | — | — | — | — | 3 | — | 3 |
Intestinal diseases | D007410 | — | K63.9 | — | — | — | 2 | — | 2 |
Obstructive sleep apnea | D020181 | EFO_0003918 | G47.33 | — | — | — | 2 | — | 2 |
Urologic neoplasms | D014571 | — | C64-C68 | — | — | — | 2 | — | 2 |
Neoplasms | D009369 | — | C80 | — | — | — | 2 | — | 2 |
Delayed emergence from anesthesia | D055191 | — | — | — | — | — | 2 | — | 2 |
Urinary retention | D016055 | — | R33 | — | — | 1 | 1 | — | 2 |
Chronic obstructive pulmonary disease | D029424 | EFO_0000341 | J44.9 | — | — | — | 1 | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
General anesthesia | D000768 | — | — | — | 6 | 12 | — | — | 18 |
Renal insufficiency | D051437 | — | N19 | 1 | — | 2 | — | — | 3 |
Elective surgical procedures | D017558 | — | — | — | — | 1 | — | — | 1 |
Replacement arthroplasty knee | D019645 | — | — | — | — | 1 | — | — | 1 |
Replacement arthroplasty hip | D019644 | — | — | — | — | 1 | — | — | 1 |
Hip fractures | D006620 | EFO_0003964 | S72.00 | — | — | 1 | — | — | 1 |
Blood coagulation | D001777 | GO_0007596 | — | — | — | 1 | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Hypersensitivity | D006967 | EFO_0003785 | T78.40 | 2 | — | — | — | — | 2 |
High-frequency jet ventilation | D006611 | — | — | 1 | — | — | — | — | 1 |
Anaphylaxis | D000707 | — | T78.2 | 1 | — | — | — | — | 1 |
Indication | MeSH | Ontology | ICD-10 | Ph 1 | Ph 2 | Ph 3 | Ph 4 | Other | Total |
---|---|---|---|---|---|---|---|---|---|
Thoracic surgical procedures | D019616 | — | — | — | — | — | — | 1 | 1 |
Pulmonary atelectasis | D001261 | — | J98.1 | — | — | — | — | 1 | 1 |
One-lung ventilation | D061810 | — | — | — | — | — | — | 1 | 1 |
Ventral hernia | D006555 | EFO_1001866 | K43 | — | — | — | — | 1 | 1 |
Hernia | D006547 | — | K40-K46 | — | — | — | — | 1 | 1 |
Pneumoperitoneum | D011027 | — | — | — | — | — | — | 1 | 1 |
Prostatic neoplasms | D011471 | — | C61 | — | — | — | — | 1 | 1 |
Kidney neoplasms | D007680 | EFO_0003865 | C64 | — | — | — | — | 1 | 1 |
Drug common name | Sugammadex |
INN | sugammadex |
Description | Sugammadex is an octasaccharide derivative that is gamma-cyclodextrin in which all eight primary hydroxy groups are replaced by 2-(carboxyethyl)sulfanyl groups. Used (as the octasodium salt) for reversal of neuromuscular blockade induced by rocuronium and vecuronium in adults undergoing surgery. It has a role as a neuromuscular agent. It is an octasaccharide derivative and an organic sulfide. It is functionally related to a gamma-cyclodextrin. It is a conjugate acid of a sugammadex(8-). |
Classification | Oligosaccharide |
Drug class | — |
Image (chem structure or protein) | ![]() |
Structure (InChI/SMILES or Protein Sequence) | O=C(O)CCSC[C@H]1O[C@@H]2O[C@@H]3[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]4[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]5[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]6[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]7[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]8[C@@H](CSCCC(=O)O)O[C@H](O[C@@H]9[C@@H](CSCCC(=O)O)O[C@H](O[C@H]1[C@H](O)C2O)[C@H](O)[C@H]9O)[C@H](O)[C@H]8O)[C@H](O)[C@H]7O)[C@H](O)[C@H]6O)[C@H](O)[C@H]5O)[C@H](O)[C@H]4O)[C@H](O)[C@H]3O |
PDB | — |
CAS-ID | 343306-71-8 |
RxCUI | — |
ChEMBL ID | CHEMBL2111107 |
ChEBI ID | — |
PubChem CID | 6918585 |
DrugBank | DB06206 |
UNII ID | 361LPM2T56 (ChemIDplus, GSRS) |